Research comparison
CJC-1295 vs GHRP-6
Side-by-side comparison of research status, mechanisms, pharmacokinetics, and administration routes.
CJC-1295 is a modified GHRH analog with a Drug Affinity Complex (DAC) that binds to serum albumin, dramatically extending its half-life compared to native GHRH. It produces sustained elevation of GH and IGF-1 levels over days rather than hours. Research focuses on body composition improvements, muscle growth, and fat loss through prolonged GH axis stimulation.
Research Status
Preclinical Research
Half-Life
6–8 days (due to DAC albumin binding)
Molecular Formula
C₁₅₂H₂₅₂N₄₂O₄₂S
Molecular Weight
3647.28 Da
CAS Number
863288-34-0
Research Categories
Growth Hormone Axis
Routes of Administration
GHRP-6 is one of the original synthetic GHRPs, acting as a strong ghrelin receptor agonist. It produces robust GH release accompanied by significant appetite stimulation — a property that makes it both valuable for cachexia research and distinct from cleaner GHRPs like Ipamorelin. Research also shows cytoprotective and cardioprotective properties independent of GH secretion.
Research Status
Preclinical Research
Half-Life
~15–60 minutes
Molecular Formula
C₄₆H₅₆N₁₂O₆
Molecular Weight
873.02 Da
CAS Number
87616-84-0
Research Categories
Growth Hormone Axis, Healing & Recovery
Routes of Administration
Full mechanism comparison
Mechanism of action, pharmacokinetics, and research findings comparison available on the Researcher plan.
Unlock full comparison →Related comparisons